SeeQC, Inc. S-1/Aamended IPO prospectus

Executive Summary

SEEQC sells quantum-control electronics, chip-fabrication and engineering services to quantum-system developers, research institutions and government programs. It aims to replace parts of room-temperature analog control systems with digital chips operating near deeply cooled quantum processors, but most revenue still comes from development and integration rather than commercial products. Revenue grew 25% Y/Y in 9M 2026, while the net loss reached $(14.3)M as development and financing-related expenses outweighed improving gross profit. The IPO is unpriced, leaving the raise, valuation and buyers’ stake undetermined; investors would be backing an unfinished technology platform that needs both customer validation and additional financing.

Business Model and Growth Drivers

SEEQC’s opportunity is to supply infrastructure needed to scale quantum computers, rather than build quantum processors or sell end-user computing services. Its platform combines superconducting Single Flux Quantum logic with cryogenic semiconductor electronics, firmware and software. Planned functions include digital qubit control, readout, multiplexing, rapid feedback and interfaces with classical processors and graphics processors. Moving these functions closer to qubits could reduce wiring, power consumption, heat and latency while supporting error correction. These remain design objectives rather than proven commercial-scale results: individual functional blocks have been tested, but unified integration remains unfinished.

Commercial foundry services provide an existing business while the platform develops. In FY2025, ≈95% of revenue came from quantum-related activities, including engineering and integration, and ≈5% from fully commercialized products. Contracts are generally fixed-price or cost-reimbursable-plus-fee; delivery, acceptance and milestones make revenue uneven. Customer integration can take ≈12–24 months or longer.

IBM and IQM relationships include engineering and foundry work; NVIDIA collaboration concerns graphics-processor interfaces. These relationships offer validation opportunities, not quantified volume commitments. Two U.S. federal agencies supplied 52% of FY2025 revenue and another customer supplied 26%, making program continuation more consequential than broad quantum-market forecasts.

SEEQC operates its own prototype and limited-production foundry and is developing a second manufacturing line with ITRI. Expansion must establish reliable yields and customer compatibility while competing against in-house technology and vendors including Keysight, Qblox and Quantum Machines.

The Offering

• Size and valuation: This preliminary IPO has no stated price range, offering share count or post-offering share count. Gross proceeds, implied market capitalization, revenue multiple, buyers’ stake and fully diluted post-offering capitalization therefore cannot yet be computed.
• Distribution: The disclosed sale is company-issued common stock. Cantor Fitzgerald, BTIG, Needham and Craig-Hallum are underwriting, with commissions up to 7.0% and a 30-day additional-share option. Closing requires Nasdaq listing approval under SEQC.
• Money recipients: Proceeds would fund general corporate purposes, including product development and capital expenditures, but also an expected settlement payment to Allegro of up to $2.0M. The settlement additionally requires 106,809 shares, described as $6.0M of consideration using a $1.3B pre-money valuation—not an established IPO valuation. SEEQC may substitute $0.5M more stock for cash.
• Capitalization bridge: After-IPO figures would reflect preferred-stock conversion, a stock split, accelerated restricted-stock vesting, executive-loan forgiveness and related taxes, settlement and advisor shares, offering costs and new proceeds. Adjusted balances and per-share tangible-asset backing remain unquantified.
• Resale restrictions: Executives, directors and holders of substantially all common stock generally face 180-day lock-ups from the eventual prospectus date, subject to exceptions and underwriter waivers. Their expiry could release substantial additional supply.

Key Financial Highlights

Amounts in $M except percentages. Results are historical; 9M periods are unaudited.

• Growth quality: FY2025 revenue rose 420% from a small base; fixed-price contracts contributed $3.70M vs $0.645M. The latest growth reflects milestone timing, not a fundamental portfolio change.
• Expense pressure: Additional IPO and financing professional fees contributed $2.3M to 9M 2026 selling, general and administrative expense growth; grant offsets also fell by $0.598M.
• Liquidity: Preferred financing supplied ≈$29.0M in FY2025, but subsequent spending depleted cash. Management now identifies insufficient resources for the following 12 months.
• Nonoperating effects: FY2024 included a $1.49M noncash convertible-note valuation expense. The IPO is expected to trigger further compensation and settlement expenses whose final accounting is unfinished.

Governance and Control

• Common stock carries one vote per share. Seven large holders owned 57.2% before the offering, assuming preferred conversion; final ownership depends on IPO terms. John Levy remains CEO and Executive Chairman.
• A staggered board, removal only for cause and a 66⅔% voting threshold make management or control changes harder.
• Outstanding options, restricted shares and restricted stock units covered 4.55M shares at 9/30/2026. Options alone had $109M intrinsic value, versus $1.42M of total stock-based compensation expense during 9M 2026; accounting expense uses grant-date values.
• The IPO will forgive $0.704M of loans to Levy and Oleg Mukhanov and fund their associated tax gross-ups. New equity and employee-purchase plans permit annual reserve increases of up to 5% and 1%, respectively.

Risk Assessment

• Going concern and controls: Management identifies substantial doubt about continued operations, alongside three unremediated material weaknesses covering accounting staffing, formal controls and information-system access.
• Unproven integration: Tested components must become a reliable customer-deployed platform; delays could consume funding before repeatable product sales emerge.
• Concentrated, cancelable demand: Dependence on a few customers and government programs exposes revenue to project cancellations, appropriations and contract renewals.
• Manufacturing dependency: The existing foundry sublease has expired while renewal is negotiated, and the second line remains under development.
• Dilution and resale: Financing needs, equity awards and the lock-up expiry could dilute ownership or pressure trading prices.

What to Watch

• Product conversion: Commercial products supplied only ≈5% of FY2025 revenue. Later filings should show integrated deployments and repeat orders, rather than prolonged evaluations.
• Customer durability: Federal agencies supplied 52% of FY2025 revenue. Renewals and broader commercial sales would strengthen the case; program losses would expose concentration.
• Manufacturing execution: ITRI’s second line is under development. Successful process transfer and dependable deliveries would validate expansion; delays would preserve single-site dependence.
• Funding sufficiency: Cash stood at $15.0M before the IPO. Final proceeds and subsequent cash flows must support development beyond near-term obligations; another urgent raise would indicate continuing financing dependence.